Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
affordable care act
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
4
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
clinical trials
deals
johnson & johnson
abeona therapeutics
aducanumab
alzheimer's
alzheimer's disease
biogen
biotech
eli lilly
fda
gene therapy
What
bio
4
×
roundup
nash
alzheimer’s
biogen’s
drug
news
aducanumab
american
amyloid
angst
approval
bagged
based
best
billions
biogen
biopharmaceutical
brammer
companies
congress
continue
convo
crash
debate
democrats
divided
earlier
effects
elections
failure
failures
fallout
felt
healthcare
industry
kind
littered
losses
lost
Language
Current search:
bio
×
" affordable care act "
×
" life sciences "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel